Trulicity - supply shortage
Shortage resolved
dulaglutide
ShortageHuman
Estonian is available via eTranslation, the European Commission's machine translation service.
Translate to Estonian | Important information about machine translation
Shortage information
The shortage affecting Trulicity has been resolved and the information and recommendations which were issued during the shortage no longer apply.
Key facts
- Medicines affected
- Trulicity
- Supply shortage status
- Shortage resolved
- International non-proprietary name (INN) or common name
- dulaglutide
- Therapeutic area (MESH)
- Diabetes Mellitus, Type 2
- Pharmaceutical forms affected
- Solution for injection in pre-filled pen
- Strengths affected
- 0.75 mg
- 1.5 mg
- 3 mg
- 4.5 mg
- Availability of alternatives
- Yes
Key dates
- Expected resolution
- End of 2025
- First published
- Last updated